{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:55:41Z","timestamp":1791665741046,"version":"4.3.4"},"reference-count":107,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The focus of pathology as a biomedical discipline is the identification of the pathomechanisms of diseases and the integration of this knowledge into routine diagnosis and classification. Standard tools are macroscopic and microscopic analysis complemented by immunohistochemistry and molecular pathology. So far, classification has been based on the paradigm of cellular pathology established by Rudolf Virchow and others more than 150 years ago, stating that diseases originate from diseased cells. This dogma is meanwhile challenged by the fact that cells can be fully reprogrammed. Many diseases are nowadays considered to originate from undifferentiated stem cells, induced into a diseased state by genetic or epigenetic alterations. In addition, the completion of the Human Genome Project, with the identification of more than 20.000 genes and a much higher number of gene variants and mutations, led to the concept that diseases are dominated by genetics\/epigenetics rather than cells of origin. The axiom of cellular pathology, however, still holds true, as cells are the smallest animate units from which diseases originate. Medical doctors and researchers nowadays have to deal with a tremendous amount of data. The International Classification of Diseases will expand from 14.400 entities\/codes in ICD-10 to more than 55.000 in ICD-11. In addition, large datasets generated by \u201cgenomics\u201c, e.g., whole-genome sequencing, expression profiling or methylome analysis, are meanwhile not only applied in research but also introduced into clinical settings. It constitutes a major task to incorporate all the data into routine medical work. Pathway pathology may help solve this problem. It is based on the realization that diseases are characterized by three essential components: (i) cells of origin\/cellular context and (ii) the alteration of cellular as well as (iii) molecular\/signal transduction pathways. The concept is illustrated by elaborating on two key cellular pathways, i.e., the cellular senescence of normal cells and the immortality of cancer cells, and by contrasting single cell\/single pathway diseases, such as mycoplasma and coughing pneumonia, with complex diseases such as cancer, with multiple cell types as well as multiple affected cellular and signaling pathways. Importantly, the concept of pathway pathology is not just intended to classify disease, but also to conceive new treatment modalities. This article is dedicated to Dr. Leonard Hayflick, who made basic discoveries in pathway pathology not only by identifying cells causing disease (Mycoplasma pneumoniae) and establishing cell strains for treating disease (WI-38 for viral vaccines), but also by first describing cellular senescence and immortality.<\/jats:p>","DOI":"10.3390\/ijms22179418","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T11:01:37Z","timestamp":1630321297000},"page":"9418","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Classification and Treatment of Diseases in the Age of Genome Medicine Based on Pathway Pathology"],"prefix":"10.3390","volume":"22","author":[{"given":"Iver","family":"Petersen","sequence":"first","affiliation":[{"name":"Institute of Pathology, SRH Poliklinik Gera, SRH-Wald-Klinikum Gera, Strasse des Friedens 122, D-07548 Gera, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fnins.2014.00265","article-title":"Superior pattern processing is the essence of the evolved human brain","volume":"8","author":"Mattson","year":"2014","journal-title":"Front. Neurosci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.1365-2141.2000.01988.x","article-title":"Historical review of lymphomas","volume":"109","author":"Aisenberg","year":"2000","journal-title":"Br. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2008-07-077982","article-title":"Classification of lymphoid neoplasms: The microscope as a tool for disease discovery","volume":"112","author":"Jaffe","year":"2008","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.prp.2016.11.001","article-title":"Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma","volume":"213","author":"Etzel","year":"2017","journal-title":"Pathol.-Res. Pr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1038\/onc.2013.565","article-title":"Mechanisms and consequences of constitutive NF-\u03baB activation in B-cell lymphoid malignancies","volume":"33","author":"Nagel","year":"2014","journal-title":"Oncogene"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.lungcan.2008.12.013","article-title":"Core classification of lung cancer: Correlating nuclear size and mitoses with ploidy and clinicopathological parameters","volume":"65","author":"Petersen","year":"2009","journal-title":"Lung Cancer"},{"key":"ref_7","first-page":"5325","article-title":"Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas","volume":"56","author":"Schwendel","year":"1996","journal-title":"Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1155\/2001\/374304","article-title":"Towards a Genetic-Based Classification of Human Lung Cancer","volume":"22","author":"Petersen","year":"2001","journal-title":"Anal. Cell. Pathol."},{"key":"ref_9","first-page":"1801","article-title":"Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization","volume":"54","author":"Ried","year":"1994","journal-title":"Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13784","DOI":"10.1073\/pnas.241500798","article-title":"Diversity of gene expression in adenocarcinoma of the lung","volume":"98","author":"Garber","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.1073\/pnas.96.16.9212","article-title":"Distinctive gene expression patterns in human mammary epithelial cells and breast cancers","volume":"96","author":"Perou","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20603-4","article-title":"Sarcoma classification by DNA methylation profiling","volume":"12","author":"Koelsche","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10039-017-0339-6","article-title":"Entit\u00e4ten der Weichteilsarkome","volume":"20","author":"Petersen","year":"2017","journal-title":"Trauma Berufskrankh."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/cgt.2015.39","article-title":"A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: A review focussing on clinical relevance","volume":"22","author":"Dietel","year":"2015","journal-title":"Cancer Gene Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102019","DOI":"10.1016\/j.ctrv.2020.102019","article-title":"Review of precision cancer medicine: Evolution of the treatment paradigm","volume":"86","author":"Tsimberidou","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"19428","DOI":"10.1073\/pnas.0709013104","article-title":"Distinguishing protein-coding and noncoding genes in the human genome","volume":"104","author":"Clamp","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","unstructured":"Kottke, J. (2021, August 28). How Many Words do Shakespeare Know. Available online: https:\/\/kottke.org\/10\/04\/how-many-words-did-shakespeare-know."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/bib\/bbr002","article-title":"The what, where, how and why of gene ontology\u2014A primer for bioinformaticians","volume":"12","author":"Dessimoz","year":"2011","journal-title":"Briefings Bioinform."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5114\/jcb.2020.94579","article-title":"SKIN-COBRA (Consortium for Brachytherapy data Analysis) ontology: The first step towards interdisciplinary standardized data collection for personalized oncology in skin cancer","volume":"12","author":"Lancellotta","year":"2020","journal-title":"J. Contemp. Brachyther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5114\/jcb.2016.61958","article-title":"ENT COBRA (Consortium for Brachytherapy Data Analysis): Interdisciplinary standardized data collection system for head and neck patients treated with interventional radiotherapy (brachytherapy)","volume":"8","author":"Tagliaferri","year":"2016","journal-title":"J. Contemp. Brachyther."},{"key":"ref_22","first-page":"1","article-title":"Rare diseases in ICD11: Making rare diseases visible in health information systems through appropriate coding","volume":"10","author":"Bellet","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_23","first-page":"1381","article-title":"Rudolf Virchow, the founder of cellular pathology","volume":"60","author":"Ribatti","year":"2019","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_24","first-page":"1101","article-title":"Cancer stem cells: Implications for cancer therapy","volume":"28","author":"Dawood","year":"2014","journal-title":"Oncology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cell.2009.03.034","article-title":"A Fresh Look at iPS Cells","volume":"137","author":"Yamanaka","year":"2009","journal-title":"Cell"},{"key":"ref_26","first-page":"477","article-title":"Intracellular growth of Pleuropneumonia-like organisms","volume":"121","author":"Hayflick","year":"1955","journal-title":"Anatomincal. Record."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1749-6632.1960.tb42709.x","article-title":"Intracellular Growth of Pleuropneumonialike Organisms (PPLO) in Tissue Culture and in OVO*","volume":"79","author":"Hayflick","year":"1960","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/br.29.2.185-221.1965","article-title":"Mycoplasma Species of Man","volume":"29","author":"Hayflick","year":"1965","journal-title":"Bacteriol. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid cell strains","volume":"25","author":"Hayflick","year":"1961","journal-title":"Exp. Cell Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41576-019-0171-x","article-title":"Context is everything: Aneuploidy in cancer","volume":"21","author":"Amon","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/2159-8290.CD-18-1220","article-title":"Tissue-Specific Oncogenic Activity of KRASA146T","volume":"9","author":"Poulin","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"a026781","DOI":"10.1101\/cshperspect.a026781","article-title":"Tumor Microenvironment and Differential Responses to Therapy","volume":"7","author":"Hirata","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_33","first-page":"240","article-title":"Preparation of Polio vaccines in a human fetal diploid cell strain","volume":"75","author":"Hayflick","year":"1962","journal-title":"Am. J. Hygiene"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3934\/publichealth.2017.2.127","article-title":"The Role of the WI-38 Cell Strain in Saving Lives and Reducing Morbidity","volume":"4","author":"Olshansky","year":"2017","journal-title":"AIMS Public Health"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1182\/blood.2019000934","article-title":"Langerhans cell histiocytosis","volume":"135","author":"Allen","year":"2020","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene Ontology: Tool for the unification of biology","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: New perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0014-4827(65)90211-9","article-title":"The limited in vitro lifetime of human diploid cell strains","volume":"37","author":"Hayflick","year":"1965","journal-title":"Exp. Cell Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Zhao, S., Wang, F., and Liu, L. (2019). Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells. Genes, 10.","DOI":"10.3390\/genes10121030"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cell.2013.10.019","article-title":"Programmed Cell Senescence during Mammalian Embryonic Development","volume":"155","author":"Maraver","year":"2013","journal-title":"Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrm3823","article-title":"Cellular senescence: From physiology to pathology","volume":"15","author":"Serrano","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cell.2013.10.041","article-title":"Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and Patterning","volume":"155","author":"Storer","year":"2013","journal-title":"Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a","volume":"88","author":"Serrano","year":"1997","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2772","article-title":"Senescence in tumours: Evidence from mice and humans","volume":"10","author":"Collado","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of Cancer: The Next Generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1158\/2159-8290.CD-14-1246","article-title":"Synovial Sarcoma: Recent Discoveries as a Roadmap to New Avenues for Therapy","volume":"5","author":"Nielsen","year":"2015","journal-title":"Cancer Discov."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.critrevonc.2017.05.009","article-title":"Reviewing the current evidence supporting early B-cells as the cellular origin of Merkel cell carcinoma","volume":"116","author":"Sauer","year":"2017","journal-title":"Crit. Rev. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11371-x","article-title":"MYC paralog-dependent apoptotic priming orchestrates a spectrum of vulnerabilities in small cell lung cancer","volume":"10","author":"Dammert","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1159\/000505892","article-title":"The Spectrum of MYC Alterations in Diffuse Large B-Cell Lymphoma","volume":"143","author":"Xia","year":"2020","journal-title":"Acta Haematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0795-2","article-title":"PTEN lipid phosphatase inactivation links the hippo and PI3K\/Akt pathways to induce gastric tumorigenesis","volume":"37","author":"Xu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/s-0033-1350831","article-title":"Multigene Assays for Classification, Prognosis, and Prediction in Breast Cancer: A Critical Review on the Background and Clinical Utility","volume":"73","author":"Sinn","year":"2013","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(16)30297-2","article-title":"Epigenetic profiling to classify cancer of unknown primary: A multicentre, retrospective analysis","volume":"17","author":"Moran","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2213-2600(18)30284-4","article-title":"Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: A multicentre, retrospective analysis","volume":"6","author":"Duruisseaux","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2213-2600(18)30333-3","article-title":"Predictive pathology of lung cancer immunotherapy response","volume":"6","author":"Petersen","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Kamps, R., Brand\u00e3o, R.D., Bosch, B.J.V.D., Paulussen, A.D.C., Xanthoulea, S., Blok, M.J., and Romano, A. (2017). Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020308"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: Utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer Genome Landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1093\/bib\/bby023","article-title":"A survey and evaluation of Web-based tools\/databases for variant analysis of TCGA data","volume":"20","author":"Zhang","year":"2019","journal-title":"Briefings Bioinform."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"a026179","DOI":"10.1101\/cshperspect.a026179","article-title":"SomaticTP53Mutations in the Era of Genome Sequencing","volume":"6","author":"Hainaut","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/carcin\/14.10.2119","article-title":"p53 mutations in phenacetin-associated human urothelial carcinomas","volume":"14","author":"Petersen","year":"1993","journal-title":"Carcinogenesis"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1126\/science.8266084","article-title":"Molecule of the year","volume":"262","author":"Koshland","year":"1993","journal-title":"Science"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/embor.2010.159","article-title":"The history of p53","volume":"11","author":"Soussi","year":"2010","journal-title":"EMBO Rep."},{"key":"ref_64","first-page":"427","article-title":"The most popular genes in the human genome","volume":"551","author":"Dolgin","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.febslet.2014.04.017","article-title":"Mutant p53 reactivation by small molecules makes its way to the clinic","volume":"588","author":"Bykov","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.tcb.2015.04.001","article-title":"Hitting cancers\u2019 weak spots: Vulnerabilities imposed by p53 mutation","volume":"25","author":"Gurpinar","year":"2015","journal-title":"Trends Cell Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in Cancer: New Functions and Therapeutic Opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fonc.2015.00288","article-title":"Targeting Oncogenic Mutant p53 for Cancer Therapy","volume":"5","author":"Parrales","year":"2015","journal-title":"Front. Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When mutants gain new powers: News from the mutant p53 field","volume":"9","author":"Brosh","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_71","first-page":"1127","article-title":"Cytoplasmic functions of the tumour suppressor p53","volume":"458","author":"Green","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/gcc.22335","article-title":"Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes","volume":"55","author":"Mertens","year":"2016","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Canale, M., Petracci, E., Delmonte, A., Bronte, G., Chiadini, E., Ludovini, V., Dubini, A., Papi, M., Baglivo, S., and De Luigi, N. (2020). Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIs. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041047"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13402-011-0013-0","article-title":"Gender and ploidy in cancer survival","volume":"34","author":"Schulze","year":"2011","journal-title":"Cell. Oncol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1200\/JCO.2017.74.9705","article-title":"Gastrointestinal Stromal Tumors","volume":"36","author":"Joensuu","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1006\/geno.2002.6744","article-title":"Molecular Cloning and Characterization of the Human S100A14 Gene Encoding a Novel Member of the S100 Family","volume":"79","author":"Pietas","year":"2002","journal-title":"Genomics"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/exd.13689","article-title":"Recent evolution of the human skin barrier","volume":"27","author":"Brettmann","year":"2018","journal-title":"Exp. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1158\/0008-5472.394.65.2","article-title":"Characterization of {gamma}-aminobutyric acid type A receptor-associated protein, a novel tumor suppressor, showing reduced expression in breast cancer","volume":"65","author":"Klebig","year":"2005","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e2205","DOI":"10.1038\/cddis.2016.93","article-title":"Tumor suppression in mice lacking GABARAP, an Atg8\/LC3 family member implicated in autophagy, is associated with alterations in cytokine secretion and cell death","volume":"7","author":"Salah","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_80","first-page":"2064","article-title":"The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Protumor Activity","volume":"10","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.prp.2017.09.021","article-title":"EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC\u2014Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP\u00ae)","volume":"213","author":"Petersen","year":"2017","journal-title":"Pathol.-Res. Pr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.prp.2018.05.004","article-title":"Stem cell transcription factor SOX2 in synovial sarcoma and other soft tissue tumors","volume":"214","author":"Zayed","year":"2018","journal-title":"Pathol.-Res. Pr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrc.2016.38","article-title":"Mechanisms of cancer dissemination along nerves","volume":"16","author":"Amit","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00238.2015","article-title":"Tumor cell intravasation","volume":"311","author":"Chiang","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prp.2011.10.009","article-title":"Morphology, DNA ploidy and HPV in lung cancer and head and neck cancer","volume":"208","author":"Kotb","year":"2012","journal-title":"Pathol.-Res. Pr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10577-015-9505-5","article-title":"Centrosome amplification, chromosomal instability and cancer: Mechanistic, clinical and therapeutic issues","volume":"24","author":"Cosenza","year":"2015","journal-title":"Chromosom. Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-017-0329-9","article-title":"Cancer immunotherapies targeting the PD-1 signaling pathway","volume":"24","author":"Iwai","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental Mechanisms of Immune Checkpoint Blockade Therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.synbio.2017.12.004","article-title":"Methods and approaches to disease mechanisms using systems kinomics","volume":"3","author":"Berard","year":"2018","journal-title":"Synth. Syst. Biotechnol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.drup.2019.100663","article-title":"Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance","volume":"48","author":"Narayanan","year":"2020","journal-title":"Drug Resist. Updat."},{"key":"ref_91","first-page":"1","article-title":"Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids","volume":"5","author":"Peifer","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Lee, M.P. (2019). Understanding Cancer Through the Lens of Epigenetic Inheritance, Allele-Specific Gene Expression, and High-Throughput Technology. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00794"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fcvm.2018.00062","article-title":"Antiinflammatory Therapy in Clinical Care: The CANTOS Trial and Beyond","volume":"5","author":"Aday","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: Exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1634\/theoncologist.11-3-306","article-title":"The Role of Statins in Cancer Therapy","volume":"11","author":"Hindler","year":"2006","journal-title":"Oncologist"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e908","DOI":"10.1097\/MD.0000000000000908","article-title":"Prognostic Significance of Statin Use in Colorectal Cancer","volume":"94","author":"Ling","year":"2015","journal-title":"Medicine"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3349\/ymj.2016.57.5.1124","article-title":"Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer","volume":"57","author":"Moon","year":"2016","journal-title":"Yonsei Med. J."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2147\/JEP.S267383","article-title":"Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy","volume":"2021","author":"Tchounwou","year":"2021","journal-title":"J. Exp. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic Cell Death in Cancer Therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-07-3293","article-title":"Oncogene Addiction","volume":"68","author":"Weinstein","year":"2008","journal-title":"Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s11684-020-0780-y","article-title":"Targeting \u201cundruggable\u201d c-Myc protein by synthetic lethality","volume":"15","author":"Wang","year":"2021","journal-title":"Front. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1158\/1078-0432.CCR-18-0968","article-title":"PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers","volume":"25","author":"Gay","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The Hallmarks of Cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","article-title":"A genetic model for colorectal tumorigenesis","volume":"61","author":"Fearon","year":"1990","journal-title":"Cell"},{"key":"ref_107","unstructured":"Mukherjee, S. (2011). The Emperor of All Maladies, Fourth Estate Ltd."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9418\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:55:54Z","timestamp":1760165754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/17\/9418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":107,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["ijms22179418"],"URL":"https:\/\/doi.org\/10.3390\/ijms22179418","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,30]]}}}